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RNAbinding proteins have thousands of cellular RNA
targets and often exhibit opposite or passive molec-
ular functions. Lin28a is a conserved RNA binding
protein involved in pluripotency and tumorigenesis
that was previously shown to trigger TuT4-mediated
pre-let-7 uridylation, inhibiting its processing and
targeting it for degradation. Surprisingly, despite
binding to other pre-microRNAs (pre-miRNAs), only
pre-let-7 is efficiently uridylated by TuT4. Thus, we
hypothesized the existence of substrate-specific co-
factors that stimulate Lin28a-mediated pre-let-7 uri-
dylation or restrict its functionality on non-let-7 pre-
miRNAs. Through RNA pull-downs coupled with
quantitative mass spectrometry, we identified the
E3 ligase Trim25 as an RNA-specific cofactor for
Lin28a/TuT4-mediated uridylation. We show that
Trim25 binds to the conserved terminal loop (CTL)
of pre-let-7 and activates TuT4, allowing for more
efficient Lin28a-mediated uridylation. These findings
reveal that protein-modifying enzymes, only recently
shown to bind RNA, can guide the function of canon-
ical ribonucleoprotein (RNP) complexes in cis,
thereby providing an additional level of specificity.
INTRODUCTION
Next-generation studies on RNA binding proteins have supplied
a constant stream of novel RNA-protein interactions (Ascano
et al., 2012; Milek et al., 2012; Ray et al., 2013). Additionally,
new clades of RNA binding proteins, such as kinases, E3 ligases,
andmetabolic enzymes, have recently been discovered by high-
throughput proteomic analysis, and their RNA-related roles are
awaiting characterization (Baltz et al., 2012; Castello et al.,
2012; Hentze and Preiss, 2010; Kwon et al., 2013). In the light
of the often short and abundant RNA sequence motifs that pro-
vide protein-binding specificity, a fundamental question is which
RNA-protein complexes are functional as opposed to being pro-
miscuous or passive.
Lin28a is an example of an RNA binding protein with a well-
defined binding motif (GGAG) and roles in the control ofCell RemicroRNA (miRNA) maturation (Heo et al., 2009; Nowak et al.,
2014; Van Wynsberghe et al., 2011; Viswanathan et al., 2008),
mRNA translation (Cho et al., 2012; Shyh-Chang et al., 2013),
andmRNAsplicing (Wilbert et al., 2012). In undifferentiatedmeta-
zoan cells, Lin28a suppresses the maturation of let-7 miRNAs by
binding to the conserved terminal loop (CTL) of the let-7 precur-
sor (pre-let-7) and recruiting the 30 terminal uridyl transferase
(TuTase) TuT4, which adds an oligouridine tail to the 30 end of
pre-let-7 (Hagan et al., 2009; Heo et al., 2009; Lehrbach et al.,
2009). The oligouridine tail inhibits cleavage by Dicer (Heo
et al., 2008) and targets pre-let-7 for degradation by the exonu-
clease Dis3L2 (Chang et al., 2013; Ustianenko et al., 2013). Other
mechanisms describing the blockage of primary microRNA (pri-
miRNAs) and pre-miRNA processing have also been suggested
(Lightfoot et al., 2011; Piskounova et al., 2008). Strikingly, even
though in vivo (Cho et al., 2012; Hafner et al., 2013; Wilbert
et al., 2012) and in vitro (Towbin et al., 2013) binding data show
that Lin28a binds many more pre-miRNAs, only some members
from the pre-let-7 family are efficiently uridylated. Hence, we pre-
dicted the existence of substrate-specific cofactors that enable
Lin28a-mediated uridylation of pre-let-7 and/or restrict its func-
tionality on non-let-7 pre-miRNAs.
Here, we show that Lin28-mediated uridylation is dependent
on the structure of the RNA and the sequence context of the
Lin28a binding motif. Using RNA pull-down combined with
high-throughput stable isotope labeling with amino acids in cell
culture (SILAC) mass spectrometry, we discovered that the E3
ligase Trim25 is a factor that binds to pre-let-7. We found that
Trim25 colocalizes and coimmunoprecipitates with Lin28a. We
also found that Trim25 activates TuT4 and that drug inhibition of
the E1 ubiquitin ligase reduces the levels of TuT4 and decreases
pre-let-7 uridylation. Finally, using in vitro pre-miRNA processing
and in vivo pre-miRNA quantification, we showed that Trim25 is
an RNA-specific cofactor for Lin28a-mediated uridylation of
pre-let-7. Altogether, our results uncover an important layer of
RNA binding factors that canmodify canonical ribonucleoprotein
(RNP) complexes and control their molecular function.
RESULTS
Lin28-Mediated Uridylation Is Dependent on RNA
Structure and the Sequence Context of the GGAG Motif
Previously, the GGAGmotif was shown to be sufficient to induce
Lin28a binding, but not uridylation (Heo et al., 2009). A fixedports 9, 1265–1272, November 20, 2014 ª2014 The Authors 1265
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Figure 1. Structural and Sequence Context
of the GGAG Motif Determine Lin28a Bind-
ing and Functionality
(A) Schematic of the secondary structure of wild-
type and conserved terminal loop (CTL) mutants of
pri-let-7a-1. Themutated nucleotides are in green,
and the GGAG motif is in red.
(B) Western blot (WB) analysis of Lin28a and DHX9
proteins in RNA pull-downs from day 0 (d0) P19
teratocarcinoma cell extract using wild-type pre-
let-7 or its CTL mutants.
(C) In vitro processing uridylation assays per-
formed with internally radiolabeled pre-let-7a
transcripts (503 103 cpm, approximately 20 pmol)
in the presence of d0 P19 cell extract.
() represents an untreated control. Reactions
were supplemented with 0.25 mM UTP. The
products were analyzed on an 8% denaturing
polyacrylamide gel.
(D) Schematic of the secondary structure of wild-
type pri-miRNA-363 and its CTL mutant.
(E) Western blot analysis of Lin28a protein in RNA
pull-downs from day 0 P19 cell extract using
wild-type pre-miRNA-363 or mutant pre-miRNA-
363@1.
(F) In vitro processing uridylation assays per-
formed with internally radiolabeled pre-miRNA-
363 transcripts (50 3 103 cpm, approximately
20 pmol) in the presence of d0 P19 cell extracts.
() represents an untreated control. Reactions
were supplemented with 0.25 mM UTP. The
products were analyzed on an 8% denaturing
polyacrylamide gel.distance between the motif and the pre-miRNA stem was
shown to determine the functionality of the complex. We sought
to test this hypothesis by testing pre-let-7a-1 and its CTL
mutants using an in vitro uridylation assay (Figure S1). Pre-let-
7a-1 mutants @2 and @3 with truncated CTLs and the naturally
occurring 30 adjacent AU dinucleotide or a UA mutation, respec-
tively, demonstrated robust Lin28a-binding efficiency (Figures 1
and S2). Importantly, despite preserving the secondary structure
and the distance of the GGAG motif from the pre-miRNA
stem, as assayed by RNA structure probing with lead ions and
ribonuclease T1 (Figure S3), pre-let-7a-1@2was efficiently uridy-
lated, but pre-let-7a-1@3 was not (Figure 1C). Pre-let-7a-1
mutant @1 with a minimal terminal loop harboring the wild-type
GGAGAU sequence did not bind Lin28a (Figure 1B), nor was it1266 Cell Reports 9, 1265–1272, November 20, 2014 ª2014 The Authorsuridylated (Figure 1C). These data point
to structural RNA constraints on Lin28a’s
interaction with its targets.
Co-overexpression of pri-let-7a-1 mu-
tants with Lin28a in HeLa cells followed
by northern blotting against let-7a
confirmed the importance of the AU dinu-
cleotide adjacent to the GGAG motif in
the Lin28a-mediated inhibition of let-7a
processing, as only the pri-let-7a-1@2
mutant was suppressed to the same
extent as the wild-type pri-let-7a-1 (Fig-ure 2). Notably, all substrates were inhibited at the Drosha
cleavage step (Figure 2), validating previous claims regarding
Lin28a-mediated repression of pri-let-7 processing (Viswana-
than et al., 2008). Finally, introduction of an AUdinucleotide adja-
cent to the GGAG motif in the terminal loop of pre-miRNA-363,
which previously had been shown to bind Lin28a but undergo
only marginal uridylation (Heo et al., 2009), greatly enhanced
its uridylation without changing its affinity for Lin28a (Figures
1D–1F). Notably, the uridylation efficiency of pre-miRNA-
363@1 was much weaker than that of pre-let-7a-1 (Figures 1C
and 1F). Overall, these results indicate that Lin28a binding
per se, even at the same distance to the stem as in wild-type
pre-let-7, is not sufficient to trigger efficient uridylation. The func-
tional role of the AU dinucleotide adjacent to the GGAG motif
let-7a
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Figure 2. Lin28a Inhibits Pri- and Pre-let-7 Processing, but the Effi-
ciency Depends on Fine Features of the Let-7 CTL
(A) Northern blot analysis with a probe for let-7a of total RNA from HeLa cells
transfected with only a pCG plasmid coding for pri-let-7a-1 or one of its CTL
mutants or cotransfected with a pri-let-7 plasmid and pCG T7-Lin28a.
(B) As a loading control, ethidium bromide (EB) staining of the polyacrylamide
gel before blotting is shown.
Cell Resuggests the existence of an additional RNA-specific cofactor
for Lin28a-mediated uridylation.
Trim25 Binds to Pre-let-7 and Interacts with
Components of the Lin28/TuT4 Pathway
To find the RNA-specific cofactor for Lin28a-mediated uridyla-
tion, we next used RNA pull-down combined with SILAC and
high-throughput mass spectrometry (Figure 3A). Pre-let-7a-1,
pre-let-7a-1@2, and pre-let-7a-1@3 pulled down 28 common
proteins, including Lin28a,with very similar efficiency (Figure 3B).
Six proteins were pulled down specifically by wild-type pre-let-
7a-1 and the @2 mutant (Figures 3B and 3C). Among them, we
identified the Trim25 protein with well-documented E3 ligase
function (Gack et al., 2007; Inn et al., 2011), which has recently
been observed to bind RNA and be downregulated during reti-
noic acid-driven differentiation (Kwon et al., 2013). We validated
Trim25 binding to the wild-type pre-let-7a-1 and pre-let-7a-1@2
mutant by RNA pull-down followed by western blotting (Fig-
ure 3D). The binding of Trim25 to the pre-let-7a-1@3 mutant
was detectable but much weaker compared to wild-type pre-
let-7a-1 and the pre-let-7a-1@2 mutant (Figures 3D and 3E).
Strikingly, despite all substrates pulling down comparable
amounts of Lin28a, only the wild-type and mutant pre-let-7a-
1@2 successfully pulled down TuT4 (Figures 3D and 3E). TuT4
was not identified in our original RNA pull-down screen, but
this could be due to lack of detection during the high-throughput
mass spectrometry. Intriguingly, even though pre-miRNA-
363@1 pulled down more TuT4 than wild-type pre-miRNA-363,
we detected similar binding of Trim25 to both substrates (Fig-
ure S4). Importantly, relative to the loading control, pull-down
of both TuT4 and Trim25 by pre-miRNA-363@1 was much less
efficient than that observed for pre-let-7a-1 (Figures S4 and
3D). This suggests a different composition of the functional
pre-miRNA-363 and pre-let-7-protein complexes and their puta-
tive roles in uridylation.
Next, we sought to establish whether Trim25 interacts with
components of the pre-let-7/Lin28/TuT4 pathway. Using immu-
nocytochemistry on mouse teratocarcinoma P19 cells, we found
that Lin28a and Trim25 colocalize in vivo, supporting their func-
tional link (Figure 3F). Notably, Lin28a and Trim25 localize to the
cytoplasm aswell as to the nucleus. Finally, using coimmunopre-
cipitation of ectopically expressed T7-Lin28a and V5-Trim25 in
HeLa cells, we validated their interaction (Figure 3G). The stabil-
ity of the complex in the presence of ribonuclease (RNase) points
either to direct interaction, which is unlikely because mutant pre-
let-7a-1@3 binds Lin28a, but not Trim25 (Figure 3D), or close
proximity binding on the same RNA. Altogether, our results
show that Trim25 could function as an RNA-specific cofactor
for the Lin28a-mediated uridylation of pre-let-7.
Trim25 Is an RNA-Specific Cofactor for Lin28a/
TuT4-Mediated Uridylation
To determine whether Trim25 plays a role in Lin28a-mediated
uridylation, we performed Trim25 RNAi in mouse teratocarci-
noma P19 cells (Figure 4A). Efficient knockdown of Trim25
caused a noticeable decrease in TuT4 levels (Figure 4A), which
suggests that Trim25 has a positive effect on the TuT4 protein
level in vivo. Importantly, pre-let-7a-1 uridylation in extractsports 9, 1265–1272, November 20, 2014 ª2014 The Authors 1267
613 16
10
7
28
12
pre-let-7a-1 pre-let-7a-1@2
pre-let-7a-1@3
Light
P19 or HeLa/oe Lin28a
cell extract
5’
Heavy
Mass Spectrometry
Pull down
[   C]Arg/ [   C]Lys12 12 [   C]Arg/ [   C]Lys13 13
A
P19 or HeLa/oe Lin28a
cell extract
pre-miRNAsbeads
B
 ARFGAP1, FAM114A1, RAB10, SYAP1 ,Trim25, ZC3HAV1
C
mix
WB: TuT4
WB: Trim25
WB: Lin28a
loa
din
g c
on
tro
l
be
ad
s
pr
e-
let
-7
a-
1
pr
e-
let
-7
a-
1@
2
pr
e-
let
-7
a-
1@
3D
pre-let-7a-1
pre-let-7a-1@2
pre-let-7a-1@3
Relative RNA pull down efficiency
Trim25 TuT4 Lin28a
100
120
140
80
60
40
20
0
[%]
E
F
G
WB: V5
WB: Lin28a
loa
din
g c
on
tro
l
IgG IgG
 +
 R
Na
se
T7 T7
 +
 R
Na
se
V5-Trim25 and T7-Lin28 
co-immunoprecipitation
Figure 3. SILAC Combined with RNA Pull-Down and Mass Spectrometry Reveals Putative Cofactors for Lin28a-Mediated Uridylation
(A) Schematic of the method. P19 cells or HeLa cells overexpressing Lin28a were grown in ‘‘light’’ medium containing 12C6-arginine and 12C6-lysine or in
‘‘heavy’’ medium containing 13C6-arginine and 13C6-lysine. Next, RNA pull-down was performed with either agarose beads incubated with extract from light
HeLa cells or beads with wild-type pre-let-7a-1 or its CTL mutants covalently linked incubated with extract from heavy HeLa cells. After thorough washing, the
resulting supernatants were mixed and subjected to quantitative mass spectrometry.
(B) Venn diagrams representing numbers of overlapping proteins identified in the pull-downs with wild-type pre-let-7a-1, pre-let-7a-1@2, and pre-let-7a-1@3.
(C) Proteins identified exclusively in the pre-let-7a-1 and pre-let-7a-1@2 pull-downs.
(D) Western blot (WB) analysis of Trim25, TuT4, and Lin28a proteins in RNA pull-downs from extract of HeLa cells overexpressing Lin28a using wild-type pre-let-7
and its CTL mutants @2 and @3.
(legend continued on next page)
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Figure 4. Trim25 Is a Positive Cofactor for
theLin28a-MediatedUridylationofPre-let-7
(A) Western blot analysis of Trim25, TuT4, Lin28a,
and a-tubulin proteins in protein extracts from
P19 cells depleted of Trim25 or FAM114A1 using
RNAi. Serial dilutions of the total protein extracts
provide estimates of the linearity and limit of
detection of the western blot assay.
(B) In vitro processing assays with internally ra-
diolabeled pre-let-7a-1 transcripts (50 3 103
cpm, approximately 20 pmol) in the presence of
mock-, Trim25-, or FAM114A1-depleted P19 cell
extract. Trim25 RNAi_1 and Trim25 RNAi_2
represent results from treatment with two dif-
ferent siRNA sets. The reactions were supple-
mented with 0.25 mM UTP.
(C) Real-time quantitative RT-PCR of miRNAs
(let-7a, miRNA-302a, and miRNA-9) in P19 cells
depleted of Trim25 or FAM114A1. The values
were normalized to miRNA-16 levels. The fold
change in the abundance miRNAs mediated by
RNAi was plotted relative to values from a mock-
transfected control, which were set to one. Mean
values and SDs of three independent experi-
ments are shown.
(D) Real-timequantitativeRT-PCRof pre-miRNAs
(pre-let-7a, pre-miRNA-302a, and pre-miRNA-9)
in P19 cells depleted of Trim25 or FAM114A1. The
values were normalized to pre-miRNA-16 levels.
The fold change in the abundance of the corre-
sponding miRNA mediated by RNAi was plotted
relative to values from a mock-transfected con-
trol, which were set to one. Mean values and SDs
of three independent experiments are shown.
(E) Western blot analysis of ubiquitinated proteins
in protein extracts from P19 cells treated with
DMSO or 50 mM PYR-41 for 4 hr. As a loading
control, Coomassie blue stain is shown.
(F) Western blot analysis of TuT4 in total extracts
from P19 cells treated with DMSO or 50 mMPYR-
41 for 4 hr.
(G) In vitro processing assays with internally
radiolabeled pre-let-7a-1 transcripts (50 3
103 cpm, approximately 20 pmol) in the presence
of P19 cell extract treated with DMSO or 50 mM
PYR-41 for 4 hr.derived from cells depleted of Trim25 (by two independent small
interfering RNA [siRNA] substrates) was inhibited as seen by
substantial retention of unprocessed pre-let-7a substrate (Fig-
ure 4B). Furthermore, Trim25 knockdown did not affect mature
miRNA levels but caused 2-fold accumulation of pre-let-7a (Fig-
ures 4C and 4D). This mirrors the effects reported for TuT4
knockdown (Chang et al., 2013). Crucially, neither pre-miRNA-
302a nor pre-miRNA-9, which were previously shown to bind
Lin28a, but not undergo uridylation (Nowak et al., 2014; Wilbert(E) Quantification of the results presented in (D). The band intensities were calcula
pre-let-7a-1 pull-down.
(F) Immunofluorescence staining of Hoechst (blue), Lin28a (green), and Trim25 (red
cytoplasm. Scale bar, 10 mm.
(G) Coimmunoprecipitation between Trim25 and Lin28a was performed with cell
The extracts were incubated with anti-T7 or control immunoglobulin G (IgG) antib
blotting with anti-Lin28a or anti-V5. To control for directionality of the interaction
Cell Reet al., 2012), were affected by Trim25 knockdown (Figures 4C
and 4D). This provides evidence that Trim25 is an RNA-specific
cofactor stimulating Lin28a-mediated uridylation.
Inhibition of the Proteasome and Ubiquitin-Activating
Enzyme E1 Results in Decreased Levels and Activity
of TuT4
Because Trim25 is an E3 ubiquitin ligase, we sought to determine
whether interfering with the ubiquitination pathway would inhibitted with ImageJ software and were normalized to 100% based on the wild-type
) in P19 cells showing colocalization of Lin28a and Trim25 predominantly in the
extracts prepared from HeLa cells overexpressing T7-Lin28a and V5-Trim25.
ody bound to protein-A beads. The bound proteins were analyzed by western
, the assay was also performed in the presence of RNase.
ports 9, 1265–1272, November 20, 2014 ª2014 The Authors 1269
its downstream activity on the Lin28a/TuT4 pathway. After treat-
ing P19 cells with the E1 ubiquitin-activating enzyme inhibitor
PYR-41 (Yang et al., 2007) for 4 hr, we detected a significant
reduction in TuT4 levels, albeit with similar levels of total protein
(Figures 4E and 4F). Crucially, extracts derived from PYR-41-
treated cells were impaired in Lin28-mediated uridylation of
pre-let-7a-1 (Figure 4G). This indicates that a functional ubiquiti-
nation pathway is necessary for TuT4 stability. Altogether, these
results imply the existence of a connection between canonical
RNA binding proteins involved in RNA processing and RNA bind-
ing factors involved in protein modification.
DISCUSSION
RNA binding proteins control gene expression programs in living
cells by regulating RNA processing, modification, localization,
translation, and turnover (Glisovic et al., 2008). They predomi-
nantly recognize RNA sequences several nucleotides long that
occur frequently in various transcriptomes (Ray et al., 2013).
For example, SRSF1 and SRSF2 were found to bind 50,000
specific sequences in mammalian cells (Pandit et al., 2013).
Furthermore, large numbers of RNA binding proteins are multi-
functional, and even more strikingly, depending on the substrate
they bind, they have opposite effects on the sameRNA-process-
ing event. It has been previously shown that the multifunctional
protein hnRNP A1 stimulates pri-miRNA-18a processing (Guil
and Ca´ceres, 2007; Michlewski et al., 2008, 2010) but inhibits
the biogenesis of pri-let-7a (Michlewski and Ca´ceres, 2010a).
Furthermore, Drosha has been recently shown to promote alter-
native splicing of exon 5 of eIF4H gene in cleavage-independent
manner (Havens et al., 2014). Finally, many high-affinity RNA-
protein interactions are functionally passive (Singh and Valca´r-
cel, 2005). This raises the important question of what determines
the functionality of RNP complexes.
The RNA binding protein Lin28a is a pluripotency-promoting
factor involved in downregulation of let-7 during early develop-
ment and differentiation in metazoans (Nowak and Michlewski,
2013; Shyh-Chang and Daley, 2013). The major mechanism in-
volves binding to the CTL of pre-let-7 via the cold shock domain
(CSD) and CHCC zinc-finger domain (Choudhury and Michlew-
ski, 2012; Loughlin et al., 2012; Nam et al., 2011) and subsequent
binding of TuT4 or the closely related TuT7, which adds an
oligo-U tail to the 30 end of pre-let-7 (Hagan et al., 2009; Heo
et al., 2009; Thornton et al., 2012). Overexpression of Lin28a is
linked with induction of tumor growth (Urbach et al., 2014).
Lin28 preferentially interacts with GGAG and GNGAY motifs
(Wilbert et al., 2012), and it binds to uridine-rich elements and
isolated guanosines (Hafner et al., 2013). Importantly, a number
of pre-miRNAs, such as pre-miRNA-363, pre-miRNA-302d, and
pre-miRNA-9-1, contain the highly conserved GGAG motif and
bind Lin28a with high affinity but are not uridylated (Heo et al.,
2009; Nowak et al., 2014; Wilbert et al., 2012). This strongly sug-
gests the existence of substrate-specific coactivators or inhibi-
tors of Lin28a function.
Using RNA pull-down coupled with quantitative SILAC mass
spectrometry (Choudhury et al., 2013; Michlewski and Ca´ceres,
2010b), we identified the E3 ligase Trim25 as an RNA-specific
cofactor for the Lin28a/TuT4 uridylation pathway. Trim25 is a1270 Cell Reports 9, 1265–1272, November 20, 2014 ª2014 The Autmember of the tripartite motif (TRIM) protein family, which is
involved in the innate immune response (Versteeg et al., 2013).
Its main protein target is retinoic acid-inducible gene I (RIG-I),
the ubiquitination of which leads to type I interferon production
(Inn et al., 2011). Recently, Trim25 has been shown to bind
RNA through its coiled-coil (CC) domain and be downregulated
during retinoic acid-driven differentiation (Kwon et al., 2013).
Interestingly, another protein from the same family, Trim71, has
previously been implicated in the miRNA pathway due to its tar-
geting of Lin28b and Ago2 for canonical proteasome-dependent
degradation (Lee et al., 2014; Rybak et al., 2009). Here we show
that an E3 ligase can recognize specific RNA and positively regu-
late a protein involved in the processing of cognate RNA in cis.
Our model is that the sequence and structural features of the
pre-let-7 CTL allow efficient Trim25 binding, which in turn stabi-
lizes TuT4 leading to increased uridylation. In the future, it will be
important to determine which type of modifications are respon-
sible for this phenomenon and whether other members from the
Trim family have similar RNA-specific functions. Because there
are 75 Trim proteins annotated in the human genome, functional
overlap, redundancy, and specification are very likely (Versteeg
et al., 2013). Furthermore, pre-miRNAs, which possess efficient
Lin28a binding but are not uridylated, could lack Trim25 binding,
as seen in the case of pre-let-7a-1@3. Finally, the existence of
additional factors inhibiting Lin28a function on non-pre-let-7
substrates cannot be ruled out.
In summary, we have identified a process with extensive impli-
cations for all RNA-protein interactions. Protein-modifying en-
zymes such as kinases, phosphatases, and E3 ligases with
the ability to bind RNA can provide selectivity for RNA process-
ing events, spatially modulating the activity of canonical RNP
complexes.
EXPERIMENTAL PROCEDURES
Cell Culture
Mouse teratocarcinoma P19 cells or HeLa cells (American Type Culture
Collection) were maintained in standard Dulbecco’s modified Eagle’s medium
(DMEM) (Life Technologies), supplemented with 10% fetal bovine serum (Life
Technologies). For SILAC mass spectrometry, undifferentiated cells were
cultured in DMEM supplemented with ‘‘heavy’’ [13C]Arg/[13C]Lys isotopes,
and differentiation was performed using DMEM supplemented with ‘‘light’’
[12C]Arg/[12Lys] isotopes (Pierce SILAC Proteins Quantitation Kit, Thermo
Scientific). Where indicated, cells were treated with the E1 ubiquitin-activating
enzyme inhibitor PYR-41 (Yang et al., 2007) for 4 hr.
In Vitro Transcription and Pre-miRNA Uridylation Assays
Pre-miRNA transcripts were prepared by standard in vitro transcription with
T7 RNA polymerase in the presence of [a-32P]-uridine-5’-triphosphate
(UTP). Where indicated, pre-miRNA probes were 50 end-labeled with
[g-32P]-ATP. The templates used to generate the transcripts were prepared
by PCR amplification from larger fragments of the human genome using
primers corresponding precisely to the ends of pre-miRNAs. The pre-let-
7a-1@1, pre-let-7a-1@2, pre-let-7a-1@3, and pre-miRNA-363@1 templates
were derived using mutagenesis of the wild-type pre-miRNAs. Generation
of the template for pre-let-7a-1@16TL was described before (Nowak et al.,
2014). Gel-purified probes (503 103 counts per minute [cpm]), approximately
20 pmol) were incubated in 30 ml reaction mixtures containing 50% (v/v) total
P19 cell extract (approximately 10 mg 3 ml1), 0.5 mM ATP, 20 mM creatine
phosphate, and 3.2 mM MgCl2. The reactions were supplemented with
0.25 mM UTP and incubated at 37C for 30 min followed by phenol-chloro-
form extraction, precipitation, and 8% (w/v) denaturing gel electrophoresis.hors
The bands on the gel were visualized with a radiographic film or by exposure
to a phosphorimaging screen and subsequent scanning on a FLA-5100
scanner (Fujifilm).
RNA Pull-Down and Mass Spectrometry
RNA pull-down and mass spectrometry were performed as previously
described (Choudhury et al., 2013), with slight modifications. In brief, total
protein extracts from undifferentiated or differentiated P19 cells grown in light
[12C]Arg/[12Lys] and heavy [13C]Arg/[13C]Lys isotopes, respectively, were
incubated with in vitro-transcribed RNAs chemically coupled to agarose
beads. The incubation was followed by a series of washes with buffer G
(20 mM Tris [pH 7.5], 135 mM NaCl, 1.5 mM MgCl2, 10% (v/v) glycerol,
1 mM EDTA, 1 mM dithiothreitol, and 0.2 mM phenylmethanesulfonylfluoride).
After the final wash, the proteins associated with the beads were analyzed by
SDS-PAGE followed by in-gel digestion and mass spectrometry or western
blotting.
Western Blot Analysis
Total protein samples (100 mg per lane), isolated by sonication, were resolved
by standard NuPAGE SDS-PAGE electrophoresis with MOPS running buffer
(Life Technologies) and transferred onto a nitrocellulose membrane. The
membrane was blocked overnight at 4C with 1:10 western blocking reagent
(Roche) in Tris-buffered saline buffer with 0.1% Tween-20 (TBST). The
following day, the membrane was incubated for 1 hr at room temperature
with primary antibody solution in 1:20 western blocking reagent diluted in
TBST: rabbit polyclonal anti-Lin28a (A177) (1:1,000, Cell Signaling Technol-
ogy), rabbit polyclonal anti-Trim25 (1:1,000, Abcam), rabbit polyclonal
anti-TuT4 (1:1,000, Protein-Tech), rabbit polyclonal anti-DHX9 (1:1,000,
Protein-Tech), mouse-monoclonal anti-ubiquitin (1:1,000 Cell Signaling Tech-
nology), and mouse-monoclonal anti-b-tubulin (1:10,000, Sigma-Aldrich).
After washing in TBST, the blots were incubated with the appropriate second-
ary antibody conjugated to horseradish peroxidase and detected with
SuperSignal West Pico detection reagent (Thermo Scientific). The membranes
were stripped using ReBlot Plus Strong Antibody Stripping Solution (Chemi-
con) equilibrated in water, blocked in 1:10 western blocking solution in
TBST, and reprobed as described above.
Northern Blot Analysis
Northern blot analysis was performed as previously described (Choudhury
et al., 2013). In brief, total RNA was resolved on a 10% PAGE-urea gel. The ri-
bosomal RNA was visualized with ethidium bromide to confirm equal loading.
The RNA was transferred onto a nitrocellulose membrane (Hybond N). The
membrane was prehybridized overnight at 40C with 10 ml of hybridization
buffer (1 3 saline sodium citrate [SSC], 1% SDS, 200 mg 3 ml1, single-
stranded DNA). A northern probe was prepared using the mirVana miR Probe
Construction Kit (Life Technologies) and hybridized against the membrane for
2 hr at 40C in 10 ml of hybridization buffer. Subsequently, the membrane was
washed with wash buffer (0.2% SSC, 0.2% SDS). The signal was registered
with radiographic film or exposed to a phosphorimaging screen and scanned
on a FLA-5100 scanner (Fujifilm).
RNAi, miRNA, and Protein Overexpression
Pools of siRNAs were obtained from Dharmacon in the format of three inde-
pendent siRNAs targeting different regions of the mRNA coding for the protein
of interest. Genomic fragments containing miRNAs were cloned into the pCG
T7 plasmid and transiently expressed in HeLa cells. Four micrograms of siRNA
was delivered in two transfection events separated by 48 hr using nucleofec-
tion technology (AMAXA), according to the manufacturer’s instructions. HeLa
cells transfections were performed using Lipofectamine 2000 (Life Technolo-
gies) according to the manufacturer’s instructions.
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